Summit Technology gets FDA approval for photorefractive keratectomy (PRK) laser
This article was originally published in Clinica
Summit Technology has received US FDA approval for its excimer laser for treating photorefractive keratectomy. Summit, which is the first and only company to receive approval for its laser system for correcting short-sightedness, was notified that the product was approvable in September (see Clinica 673, p 17). PRK treatment involves the use of the laser to deliver pulses of ultraviolet light to remove thin layers from the corneal surface. Summit's laser system was approved for phototherapeutic keratectomy last March.